Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis.

MLA

Sermet-Gaudelus, Isabelle, et al. “Antisense Oligonucleotide Eluforsen Improves CFTR Function in F508del Cystic Fibrosis.” Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 18, no. 4, July 2019, pp. 536–42. EBSCOhost, https://doi.org/10.1016/j.jcf.2018.10.015.

APA

Sermet-Gaudelus, I., Clancy, J. P., Nichols, D. P., Nick, J. A., De Boeck, K., Solomon, G. M., Mall, M. A., Bolognese, J., Bouisset, F., den Hollander, W., Paquette-Lamontagne, N., Tomkinson, N., Henig, N., Elborn, J. S., & Rowe, S. M. (2019). Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, 18(4), 536–542. https://doi.org/10.1016/j.jcf.2018.10.015

Chicago

Sermet-Gaudelus, Isabelle, John P Clancy, David P Nichols, Jerry A Nick, Kris De Boeck, George M Solomon, Marcus A Mall, et al. 2019. “Antisense Oligonucleotide Eluforsen Improves CFTR Function in F508del Cystic Fibrosis.” Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 18 (4): 536–42. doi:10.1016/j.jcf.2018.10.015.